FLOVENT HFA
FLOVENT HFA
Approved
DIN Number
02244293
Drug Class
Human
Market Date
Dec 20, 2001
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02244293
AIG Number0124685003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03BA05 FLUTICASONE
Product Specifications
Dosage FormMetered-Dose Aerosol
Route of AdministrationInhalation
,
Oral
AHFS Classification68:04.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
FLUTICASONE PROPIONATEActive
Strength: 250 MCG / ACT
Monograph: FLUTICASONE PROPIONATE